Cargando…
Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegia...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547129/ https://www.ncbi.nlm.nih.gov/pubmed/34698976 http://dx.doi.org/10.1007/s11136-021-03017-7 |
_version_ | 1784590324892434432 |
---|---|
author | Moshina, Nataliia Falk, Ragnhild S. Botteri, Edoardo Larsen, Marthe Akslen, Lars A. Cairns, John A. Hofvind, Solveig |
author_facet | Moshina, Nataliia Falk, Ragnhild S. Botteri, Edoardo Larsen, Marthe Akslen, Lars A. Cairns, John A. Hofvind, Solveig |
author_sort | Moshina, Nataliia |
collection | PubMed |
description | PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer and investigate quality adjusted life years (QALYs) for women with breast cancer from the third to 14th year since diagnosis. METHODS: This retrospective cross-sectional study was focused on women aged 50 and older. A self-reported questionnaire including EQ-5D-5L was sent to 11,500 women. Multivariable median regression was used to analyze the association between quality of life score (visual analogue scale 0–100) and detection mode. Health utility values representing women’s health status were extracted from EQ-5D-5L. QALYs were estimated by summing up the health utility values for women stratified by detection mode for each year between the third and the 14th year since breast cancer diagnosis, assuming that all women would survive. RESULTS: Adjusted regression analyses showed that women with screen-detected (n = 1206), interval cancer (n = 1005) and those without breast cancer (n = 1255) reported a higher median quality of life score using women with symptomatic cancer (n = 1021) as reference; 3.7 (95%CI 2.2–5.2), 2.3 (95%CI 0.7–3.8) and 4.8 (95%CI 3.3–6.4), respectively. Women with symptomatic, screen-detected and interval cancer would experience 9.5, 9.6 and 9.5 QALYs, respectively, between the third and the 14th year since diagnosis. CONCLUSION: Women with screen-detected or interval breast cancer reported better quality of life compared to women with symptomatic cancer. The findings add benefits of organized mammographic screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03017-7. |
format | Online Article Text |
id | pubmed-8547129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85471292021-10-27 Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway Moshina, Nataliia Falk, Ragnhild S. Botteri, Edoardo Larsen, Marthe Akslen, Lars A. Cairns, John A. Hofvind, Solveig Qual Life Res Article PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer and investigate quality adjusted life years (QALYs) for women with breast cancer from the third to 14th year since diagnosis. METHODS: This retrospective cross-sectional study was focused on women aged 50 and older. A self-reported questionnaire including EQ-5D-5L was sent to 11,500 women. Multivariable median regression was used to analyze the association between quality of life score (visual analogue scale 0–100) and detection mode. Health utility values representing women’s health status were extracted from EQ-5D-5L. QALYs were estimated by summing up the health utility values for women stratified by detection mode for each year between the third and the 14th year since breast cancer diagnosis, assuming that all women would survive. RESULTS: Adjusted regression analyses showed that women with screen-detected (n = 1206), interval cancer (n = 1005) and those without breast cancer (n = 1255) reported a higher median quality of life score using women with symptomatic cancer (n = 1021) as reference; 3.7 (95%CI 2.2–5.2), 2.3 (95%CI 0.7–3.8) and 4.8 (95%CI 3.3–6.4), respectively. Women with symptomatic, screen-detected and interval cancer would experience 9.5, 9.6 and 9.5 QALYs, respectively, between the third and the 14th year since diagnosis. CONCLUSION: Women with screen-detected or interval breast cancer reported better quality of life compared to women with symptomatic cancer. The findings add benefits of organized mammographic screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03017-7. Springer International Publishing 2021-10-26 2022 /pmc/articles/PMC8547129/ /pubmed/34698976 http://dx.doi.org/10.1007/s11136-021-03017-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Moshina, Nataliia Falk, Ragnhild S. Botteri, Edoardo Larsen, Marthe Akslen, Lars A. Cairns, John A. Hofvind, Solveig Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title | Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title_full | Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title_fullStr | Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title_full_unstemmed | Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title_short | Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway |
title_sort | quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from norway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547129/ https://www.ncbi.nlm.nih.gov/pubmed/34698976 http://dx.doi.org/10.1007/s11136-021-03017-7 |
work_keys_str_mv | AT moshinanataliia qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT falkragnhilds qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT botteriedoardo qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT larsenmarthe qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT akslenlarsa qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT cairnsjohna qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway AT hofvindsolveig qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway |